APA (7th ed.) Citation

Tarawneh, A. H., Pandey, P., Al-Momani, L. A., Gadetskaya, A. V., Abu-Orabi, S. T., Doerksen, R. J., & Cutler, S. J. (2022). 1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists. Elsevier.

Chicago Style (17th ed.) Citation

Tarawneh, Amer H., Pankaj Pandey, Lo'ay A. Al-Momani, Anastassiya V. Gadetskaya, Sultan T. Abu-Orabi, Robert J. Doerksen, and Stephen J. Cutler. 1,2,3-Triazole Derivatives as Highly Selective Cannabinoid Receptor Type 2 (CB2) Agonists. Elsevier, 2022.

MLA (8th ed.) Citation

Tarawneh, Amer H., et al. 1,2,3-Triazole Derivatives as Highly Selective Cannabinoid Receptor Type 2 (CB2) Agonists. Elsevier, 2022.